Position in NBP
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,148,589
+$885,408 QoQ
Shares Held
589,020
+835.5% QoQ
Ownership
0.509%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#12
of 49 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026E Fund Management Co., Ltd. holds $66,669,985 across 110 Biotechnology names. NBP ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,455 | $5,690,042 | |
| 2 | ERAS |
Erasca, Inc.
|
265,381 | $4,861,779 | |
| 3 | CELC |
Celcuity Inc.
|
45,895 | $4,801,534 | |
| 4 | EYPT |
EyePoint, Inc.
|
330,774 | $4,730,068 | |
| 5 | AVBP |
ArriVent BioPharma, Inc.
|
109,328 | $3,798,054 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,158 | $3,216,219 | |
| 7 | LEGN |
Legend Biotech Corp
|
109,327 | $3,157,363 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,073 | $1,828,155 |
All Filings in NBP
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,148,589 | 589,020 | Shares | Sole | 2026-08-11 | |
| 2022-12-31 | $263,181 | 62,962 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $409,649 | 102,157 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,657,374 | 412,157 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,061,525 | 434,823 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $18,423,952 | 388,773 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $24,910,971 | 343,647 | Shares | Defined | 2021-11-12 | |
| 2021-03-31 | $17,248,776 | 355,865 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||